Whiteside TL - Search Results

1

Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697).

Lawson DH, Lee S, Zhao F, Tarhini AA, Margolin KA, Ernstoff MS, Atkins MB, Cohen GI, Whiteside TL, Butterfield LH, Kirkwood JM. Lawson DH, et al. Among authors: whiteside tl. J Clin Oncol. 2015 Dec 1;33(34):4066-76. doi: 10.1200/JCO.2015.62.0500. Epub 2015 Sep 8. J Clin Oncol. 2015. PMID: 26351350 Free PMC article. Clinical Trial.

2

Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells.

Jost LM, Kirkwood JM, Whiteside TL. Jost LM, et al. Among authors: whiteside tl. J Immunol Methods. 1992 Mar 4;147(2):153-65. doi: 10.1016/s0022-1759(12)80003-2. J Immunol Methods. 1992. PMID: 1548398

3

Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial.

Ernstoff MS, Gooding W, Nair S, Bahnson RR, Miketic LM, Banner B, Day R, Whiteside T, Titus-Ernstoff L, Kirkwood JM. Ernstoff MS, et al. Cancer Res. 1992 Feb 15;52(4):851-6. Cancer Res. 1992. PMID: 1737346 Clinical Trial.

4

Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells.

Sedlmayr P, Rabinowich H, Elder EM, Ernstoff MS, Kirkwood JM, Herberman RB, Whiteside TL. Sedlmayr P, et al. Among authors: whiteside tl. J Immunother (1991). 1991 Oct;10(5):336-46. doi: 10.1097/00002371-199110000-00005. J Immunother (1991). 1991. PMID: 1790141

5

Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Confirmation of a model.

Levy SM, Herberman RB, Lee J, Whiteside T, Kirkwood J, McFeeley S. Levy SM, et al. Nat Immun Cell Growth Regul. 1990;9(5):313-24. Nat Immun Cell Growth Regul. 1990. PMID: 2077396

6

A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.

Ernstoff MS, Nair S, Bahnson RR, Miketic LM, Banner B, Gooding W, Day R, Whiteside T, Hakala T, Kirkwood JM. Ernstoff MS, et al. J Clin Oncol. 1990 Oct;8(10):1637-49. doi: 10.1200/JCO.1990.8.10.1637. J Clin Oncol. 1990. PMID: 2120392

7

Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients.

Levy SM, Herberman RB, Whiteside T, Sanzo K, Lee J, Kirkwood J. Levy SM, et al. Psychosom Med. 1990 Jan-Feb;52(1):73-85. doi: 10.1097/00006842-199001000-00006. Psychosom Med. 1990. PMID: 2305024

8

Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.

Weidmann E, Logan TF, Yasumura S, Kirkwood JM, Trucco M, Whiteside TL. Weidmann E, et al. Among authors: whiteside tl. Cancer Res. 1993 Oct 15;53(20):4745-9. Cancer Res. 1993. PMID: 8402652

9

Phase II trial of interferon-alpha in locally recurrent or metastatic squamous cell carcinoma of the head and neck: immunological and clinical correlates.

Vlock DR, Andersen J, Kalish LA, Johnson JT, Kirkwood JM, Whiteside T, Herberman RB, Adams GS, Oken MM, Haselow RE. Vlock DR, et al. J Immunother Emphasis Tumor Immunol. 1996 Nov;19(6):433-42. doi: 10.1097/00002371-199611000-00008. J Immunother Emphasis Tumor Immunol. 1996. PMID: 9041463 Clinical Trial.

10

Immunomodulatory function of interferon-gamma in patients with metastatic melanoma: results of a phase II-B trial in subjects with metastatic melanoma, ECOG study E 4987. Eastern Cooperative Oncology Group.

Kirkwood JM, Bryant J, Schiller JH, Oken MM, Borden EC, Whiteside TL. Kirkwood JM, et al. Among authors: whiteside tl. J Immunother. 1997 Mar;20(2):146-57. doi: 10.1097/00002371-199703000-00007. J Immunother. 1997. PMID: 9087387 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

701 results

Search Page